1 mg compounded semaglutide Hims & Hers stock falls 25% as FDA curtails GLP-1s Semaglutide for Weight Loss |

Not on the Bridge list

Both Wegovy and Ozempic contain semaglutide, but they are licensed for different indications Wegovy is specifically approved for weight management at a maintenance dose of 2.4 mg weekly, while Ozempic is licensed for type 2 diabetes at doses up to 2 mg weekly

Given the current supply landscape for GLP-1 therapies, compounded versions of drugs such as tirzepatide and semaglutide are intended to be prepared on a patient-specific basis pursuant to a valid prescription

This article does not predict the outcome of FDA's pending action on the 503B Bulks List or how altRx specifically will be affected